591 related articles for article (PubMed ID: 32929211)
1. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Wang QQ; Kaelber DC; Xu R; Volkow ND
Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
[TBL] [Abstract][Full Text] [Related]
2. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
Wang Q; Berger NA; Xu R
JAMA Oncol; 2021 Feb; 7(2):220-227. PubMed ID: 33300956
[TBL] [Abstract][Full Text] [Related]
3. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020.
Board AR; Kim S; Park J; Schieber L; Miller GF; Pike J; Cremer LJ; Asher A
Drug Alcohol Depend; 2022 Mar; 232():109297. PubMed ID: 35033956
[TBL] [Abstract][Full Text] [Related]
5. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
6. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
[No Abstract] [Full Text] [Related]
7. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.
Wang Q; Davis PB; Gurney ME; Xu R
Alzheimers Dement; 2021 Aug; 17(8):1297-1306. PubMed ID: 33559975
[TBL] [Abstract][Full Text] [Related]
8. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
Schieber LZ; Dunphy C; Schieber RA; Lopes-Cardozo B; Moonesinghe R; Guy GP
JAMA Psychiatry; 2023 Apr; 80(4):331-341. PubMed ID: 36790774
[TBL] [Abstract][Full Text] [Related]
10. Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records.
Tuan WJ; Kindt HM; Lennon RP
BMJ Open; 2023 Dec; 13(12):e074993. PubMed ID: 38072495
[TBL] [Abstract][Full Text] [Related]
11. Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study.
Best JH; Mohan SV; Kong AM; Patel K; Pagel JM; Ivanov B; Brawley OW; Jariwala-Parikh K; Zazzali JL; Pauk J
Adv Ther; 2020 Dec; 37(12):4981-4995. PubMed ID: 33044691
[TBL] [Abstract][Full Text] [Related]
12. HIV testing among people with and without substance use disorder in emergency departments: A nationwide cohort study.
Kimmel SD; Anderson ES; Larochelle MR
Am J Emerg Med; 2021 Oct; 48():269-272. PubMed ID: 34015610
[TBL] [Abstract][Full Text] [Related]
13. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City.
Allen B; Basaraba C; Corbeil T; Rivera BD; Levin FR; Martinez DM; Schultebraucks K; Henry BF; Pincus HA; Arout C; Krawczyk N
Prev Med; 2023 Jul; 172():107533. PubMed ID: 37146730
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems.
Krawczyk N; Rivera BD; Basaraba C; Corbeil T; Allen B; Schultebraucks K; Henry BF; Pincus HA; Levin FR; Martinez D
Addiction; 2023 May; 118(5):857-869. PubMed ID: 36459420
[TBL] [Abstract][Full Text] [Related]
16. Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020.
Acevedo A; Feng W; Corlin L; Allen JD; Levine P; Stopka TJ
PLoS One; 2022; 17(7):e0271788. PubMed ID: 35862354
[TBL] [Abstract][Full Text] [Related]
17. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults.
Kahle EM; Veliz P; McCabe SE; Boyd CJ
Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027
[TBL] [Abstract][Full Text] [Related]
18. Patient and Hospital Factors Associated With Differences in Mortality Rates Among Black and White US Medicare Beneficiaries Hospitalized With COVID-19 Infection.
Asch DA; Islam MN; Sheils NE; Chen Y; Doshi JA; Buresh J; Werner RM
JAMA Netw Open; 2021 Jun; 4(6):e2112842. PubMed ID: 34137829
[TBL] [Abstract][Full Text] [Related]
19. Menthol cigarette smoking among individuals in treatment for substance use disorders.
Gubner NR; Williams DD; Pagano A; Campbell BK; Guydish J
Addict Behav; 2018 May; 80():135-141. PubMed ID: 29407684
[TBL] [Abstract][Full Text] [Related]
20. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data.
Wu LT; Zhu H; Ghitza UE
Drug Alcohol Depend; 2018 Nov; 192():316-323. PubMed ID: 30312893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
